About Hemab Therapeutics Holdings, In (COAG) data
Data as of September 30, 2026.
Hemab Therapeutics Holdings, In (COAG) has 3.39M shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 28.36% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 4.18 days (days to cover).
Frequently asked questions
What is the current short interest in COAG?
As of the latest FINRA settlement dated September 30, 2026, COAG had approximately 3,390,130 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short COAG?
The latest borrow fee (cost to borrow) for COAG is 1.96% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for COAG?
Days to cover for COAG is approximately 4.18 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
How many COAG shares failed to deliver?
On September 30, 2026, the latest settlement date in the SEC's fails-to-deliver data, 15,392 shares of COAG had failed to deliver, worth about $501.78K at the prior day's close (0.03% of shares outstanding). That is the balance still outstanding that day, not new fails. Fails come from long sales and delivery delays as well as short sales.
Is COAG a short squeeze candidate?
A squeeze needs shorts that are hard to close. COAG trades about 811,205 shares a day and would take roughly 4.18 days to unwind current short positions, at a current borrow fee of 1.96%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.